Objective: To examine the relationship between the direction of renal cell carcinoma 22 growth and the visceral/perirenal fat volume. 23 Patients and Methods: We retrospectively reviewed computed tomography scans of 153 24 patients with stage 1 renal cell carcinoma who underwent radical or partial nephrectomy 25 in our hospital between January 2013 and July 2016. We calculated the 26 visceral/subcutaneous/perirenal fat volumes using SYNAPSE VINCENT ® . Of the 60 27 patients, the perirenal fat was immunohistochemically stained for leptin, adiponectin, 28 COX-2 and UCP-1, and the association with outward tumor protrusion was evaluated. 29 Results: Of the 153 cases, 88 had confirmed outward expansion (57.5%), 110 were 30 classed as pT1a (52 and 58 with outer and inner expansion, respectively), 43 were classed 31 as pT1b (36 and 7 with outer and inner expansion, respectively; P<0.0001). Multivariate 32 logistic regression model showed a trend toward significance in pT1b (vs pT1a, [OR] 33 6.033, 95%CI=2.409-15.108, P=0.0001), perirenal fat percentage >1.0 (vs ≤1.0, [OR] 34 2.596, 95%CI=1.205-5.591, P=0.014). as independent predictors for outer protrusion.
Introduction 45
Renal cell carcinoma (RCC) consists of a heterogeneous group of cancers that are 46 derived from the nephron. Various histological and molecular RCC subtypes exist. The 47 international TNM staging system is used to classify RCC because it reflects patient 48 outcomes. The TNM staging system classifies RCC according to the size of the tumor 49 and the grade of extension. In recent years, partial nephrectomy has been the standard 50 surgical treatment for T1a tumors (<4 cm) and select T1b tumors (4-7 cm). Among these 51 tumor classes, the tumor location can be divided into inner or outer. The RCC location is 52 very important to surgeons because intraparenchymal tumors are relatively hard to 53 partially resect and have high perioperative complications [1] . Furthermore, slow-54 growing RCCs tend to be outwardly located in comparison with rapidly growing types 55 [2]. Therefore, the tumor location may predict surgical complications and malignant 4 56 potential. However, to date, little attention has been paid to the mechanism of the pattern 57 of RCC growth. 58 There is lots of epidemiological evidence to suggest that long-standing obesity is one 59 of the primary causes of cancer; including cancers of the breast, colon, esophagus, kidney is surrounding by perirenal fat; however, no studies have been done to investigate 68 the relationship between RCC and BAT. Perirenal fat is located in the retroperitoneum 69 and is a type of visceral fat [9] . Adipose tissue is generally considered as the storage site 70 of excess energy, although recently is has been revealed that adipocytes have endocrine 71 activity and producing hormones, inflammatory cytokines and adipocytokines [10] .
72
A previous study found that prostate cancer (PCa) patients that had higher 73 periprostatic fat had more aggressive PCa [11] . Moreover, patients with metabolic 5 74 syndrome, including obesity, have poorer outcomes after radical prostatectomy [12] , and 75 obesity is a risk factor for aggressive PCa [13] . For breast cancer patients, obesity is 76 associated with advanced disease at diagnosis and with a poor prognosis [14] . Also in 77 RCC patients, thickness and stranding of perirenal fat affect progression free survival of 78 clinically localized kidney cancer [15] . These results suggest that adipose tissue may also 79 affect RCC growth. In this study, we examined the association between adipose tissue, 80 especially around kidney, and the growth pattern of RCC in patients in our hospital who 81 underwent radical or partial nephrectomy. Tokyo, Japan). To calculate the visceral fat/subcutaneous fat ratio (V/S ratio), the VF 100 volume was divided by the SF volume. The PF volume was measured by marking the 101 area of adiposity on each CT image ( Fig. 1A, B ). To calculated the PF percentage, the PF 102 volume was divided by the abdominal volume. To minimize inter-observer variation, 103 adipose tissue assessments were carried out by the same examiner. When the tumor was 104 50% or more exophytic it was classified as an 'outer location' and if it was less than 50% 105 exophytic it was classified as an 'inner location'. Ann Arbor, MI, USA) were applied, followed by a broad-spectrum secondary antibody 114 (Invitrogen, Carlsbad, CA, USA), as described previously [16] . 115 For scoring leptin, adiponectin, UCP-1 and COX-2 expression, stained cells were 116 divided into three categories as follows: 0, negative; 1, positive; and 2, strong positive. Leptin, adiponectin, COX-2 and UCP-1 expression in the perirenal fat of RCC patients 150 We immunohistochemically stained for leptin, adiponectin, COX-2 and UCP-1 in 151 samples from the 60 patients. Positive signals representing these proteins were 152 predominantly detected in adipocytes (Fig. 2) , and their expression patterns are 153 summarized in Table 3 . Leptin was detected in 3 (7.4%) of the 41 outer expansion samples Table 2 showed that pT stage and PF percentage were also independent factors for 175 tumor location. When the tumor becomes larger, it is difficult to stay in the kidney 176 therefore it is reasonable that pT stage is one of the risk factor. Even in pT1a tumor, less 177 than 4cm, PF percentage was correlated with growth pattern (Table S2 ). Together, these 178 results suggest that perirenal fat can affect the growth direction of renal tumors even if 179 pT stage is the important factor.
180
In this study, a 50% or more exophytic mass was defined as 'outer expansion' because 181 a high level of outgrowth is often easy to resect. Our classification also corresponds with 11 182 the R.E.N.A.L nephrectomy score, a classification system based on RCC anatomy [22] . 183 Anatomically, kidney cancer can grow into the renal parenchyma or into the 184 perirenal fat. The pressure inside the perirenal fat may be lower than that inside the renal 185 parenchyma; therefore, it may be easier for tumors to grow outside the kidney. This easier 186 growth may also influence the RCC shape and give rise to asymmetrical and/or non-cubic 187 tumors. However, most masses are symmetrical and cubic [22] , and it has been reported 188 that RCCs with regular shapes localize to the outside of the kidney and grow more slowly We immunohistochemically stained leptin, adiponectin, COX-2 and UCP-1 in 211 perirenal fat. The expression patterns of leptin and adiponectin did not correlate with the 212 growth pattern (Table 3) , in contrast from the results of previous studies of serum levels.
213
In most of our cases, leptin was negative (55 of 60 cases) and adiponectin was positive 214 (60 of 60 cases), and there were few cases in which expression of both adipocytokines 215 were detected. More sensitive modalities will be required in future to quantify these 216 adipocytokines. We also examined COX-2 because obesity can cause adipose tissue 217 overgrowth and inflammation associated with tumorigenesis [32]. However, COX-2 13 218 expression also did not correlate with the growth pattern in our study. UCP-1 is a marker 219 of BAT mitochondria [8] . We found that UCP-1 expression was associated with inner-220 type growth, suggesting that BAT prevents outwards RCC growth. TNFα, which are also 221 secreted by adipose tissue, inhibits UCP1 expression via extracellular-regulated kinases 222 (ERKs) [33] , and inflammation also inhibited UCP1 in mice [34] . These results suggest 223 that low expression of UCP1 may reflect the inflammation around the kidney. 
228
We propose that adipose tissue stimulates renal cancer in two ways: (i) 229 adipocytokines that are generated in visceral and/or perirenal fat reach the kidney through 230 the blood stream; or (ii), adipocytokines directly activate RCC through paracrine 231 mechanisms. In this study, we showed that RCCs in patients with thick perirenal fat tend 232 to grow outwardly, such that the RCCs protrude into areas that are rich in adipocytokines 233 and/or inflammatory cytokines. This suggests that paracrine mechanisms are more 234 important for RCC growth direction. Table 3 359 Expression of Leptin, Adiponectin, COX-2 and UCP-1 in perirenal fat. Table S1 362 Correlations between expansion pattern and characteristics of patients. Table S2 365 Correlations between expansion pattern and characteristics of pT1a patients.
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